Discriminative Dissolution Method Development Through an aQbD Approach
Open Access
- 8 December 2023
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 24 (8) , 1-11
Abstract
Using a one-factor-at-a-time approach for dissolution method and discrimination analysis can be time-consuming and may not yield the optimal and discriminative method. To address this, we have developed a two-stage workflow for the dissolution method development followed by demonstration of discrimination power through an analytical Quality by Design (aQbD) approach. In the first stage, an optimal dissolution method was achieved by determining the method operable design region (MODR) through a design of experiment study of the high-risk method-related parameters. In the second stage, we established a Formulation-Discrimination Correlation Diagram strategy to examine the method discrimination capability, through which one can determine the method discriminative design region (MDDR) and visualize the impact of each formulation parameter and their interactions on dissolution. The application of aQbD principles into a workflow provides a scientific-driven guidance for robust method development and demonstrating discrimination power for dissolution methods. Graphical AbstractKeywords
This publication has 48 references indexed in Scilit:
- Impact of Quality by Design in Process Development on the Analytical Control Strategy for a Small-Molecule Drug SubstanceJournal of Pharmaceutical Innovation, 2013
- Regulatory status on the role of in vitro dissolution testing in quality control and biopharmaceutics in EuropeBiopharmaceutics & Drug Disposition, 2013
- To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazoleDrug Development and Industrial Pharmacy, 2012
- Dissolution Testing for Generic Drugs: An FDA PerspectiveThe AAPS Journal, 2011
- Development of Quality-By-Design Analytical MethodsJournal of Pharmaceutical Sciences, 2011
- A Quality by Design approach to investigate tablet dissolution shift upon accelerated stability by multivariate methodsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a DrugThe AAPS Journal, 2010
- Clinical Relevance of Dissolution Testing in Quality by DesignThe AAPS Journal, 2008
- Pharmaceutical Quality by Design: Product and Process Development, Understanding, and ControlPharmaceutical Research, 2008
- Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenololJournal of Pharmaceutical Sciences, 2004